Tag: Glutathione precursor amino acid combination providing glycine and N-acetylcysteine as rate-limiting substrates for intracellular glutathione biosynthesis

  • GlyNAC

    Glutathione precursor amino acid combination providing glycine and N-acetylcysteine as rate-limiting substrates for intracellular glutathione biosynthesis

    A defined combination of glycine and N-acetylcysteine developed at Baylor College of Medicine as a glutathione-replenishing intervention targeting age-associated oxidative stress, mitochondrial dysfunction, and multiple hallmarks of biological aging.

    Abstract

    GlyNAC is a defined equimolar combination of glycine and N-acetylcysteine (NAC) that supplies the two amino acid precursors whose availability limits the intracellular biosynthesis of glutathione (gamma-glutamylcysteinylglycine, GSH), the most abundant endogenous non-protein thiol antioxidant in mammalian cells. The combination was developed and systematically investigated by Rajagopal V. Sekhar and colleagues at Baylor College of Medicine beginning approximately 2018, on the basis of prior observations that aging, HIV infection, and type 2 diabetes are associated with deficient intracellular glutathione concentrations traceable to diminished availability of both glycine and cysteine rather than to reduced activity of the synthetic enzymes glutamate-cysteine ligase and glutathione synthetase. The mechanistic rationale is that NAC undergoes deacetylation to cysteine in the intestinal mucosa and liver, while supplemental glycine directly enters the glutathione synthetic pathway; co-administration of both precursors at physiologically relevant doses corrects the dual substrate deficit and restores intracellular glutathione concentrations within two weeks in human subjects, with downstream improvements in oxidative stress biomarkers, mitochondrial fatty-acid oxidation, inflammation, insulin resistance, endothelial function, genomic integrity, and cellular senescence markers.

    The principal clinical evidence derives from a series of trials conducted at Baylor College of Medicine. A subsequent double-blind, placebo-controlled randomized clinical trial in 24 older adults (aged 65 to 80 years) confirmed these findings over 16 weeks of supplementation, with additional demonstration of improvements in multiple hallmarks of aging including mitochondrial dysfunction, impaired mitophagy, inflammation, endothelial dysfunction, genomic damage, stem cell fatigue, and cellular senescence.

    Parallel investigations have extended the GlyNAC evidence base to HIV-infected adults (open-label, improvements in oxidative stress, mitochondrial function, inflammation, endothelial function, insulin resistance, strength, and cognition), type 2 diabetes (pilot study, 30 percent improvement in mitochondrial fatty-acid oxidation and 22 percent reduction in insulin resistance over 14 days), and COVID-19 (observational characterization of severe glutathione deficiency and oxidative stress in hospitalized patients). A preclinical mouse lifespan study demonstrated that GlyNAC supplementation initiated at 65 weeks of age (corresponding to late middle age in humans) extended median lifespan by 24 percent and corrected glutathione deficiency, oxidative stress, mitochondrial dysfunction, impaired mitophagy, abnormal nutrient sensing, and genomic damage in liver, heart, and kidney tissues.

    The combination is well tolerated in all published trials. No serious adverse events attributable to GlyNAC have been reported. The principal mild adverse events are gastrointestinal (nausea, bloating), attributable to the NAC component, and are dose-dependent and generally self-limiting. NAC has an established clinical safety profile as a mucolytic and acetaminophen-overdose antidote at doses substantially exceeding those used in GlyNAC research.

    This monograph reviews the chemistry, mechanism, pharmacokinetics and analytical identity of the compound, with a curated reference list.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.